Type II 5Ј-iodothyronine deiodinase (D2), produces triiodothyronine (T3) and is stimulated by cold exposure via norepinephrine (NE) release in brown adipose tissue. Cultured rat brown adipocytes require T3 for the adrenergic stimulation of D2 activity. D2 mRNA expression in cultured brown adipocytes is undetectable with the use of basal conditions or NE without T3. Full D2 expression is achieved using NE ϩ T3, especially after prolonged T3 exposure. ␤3-Adrenergic agonists mimic the NE action, whereas cAMP analogs do not. Prolonged exposure to T3 alone increases D2 mRNA. High T3 doses (500 nM) inhibit the adrenergic stimulation of D2 activity while increasing D2 mRNA. The effects obtained with NE ϩ T3 or T3 alone are suppressed by actinomycin, but not by cycloheximide, which leads to accumulation of short D2 mRNA transcripts. Prolonged or short exposure to T3 did not change D2 mRNA half-life, but T3 seemed to elongate it. In conclusion, T3 is an absolute requirement for the adrenergic stimulation of D2 mRNA in brown adipocytes. T 3 upregulates D2 mRNA, an effect that might involve stimulation of factors required for transcription or for stabilization of D2 mRNA.
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norepinephrine; uncoupling protein-1 BROWN ADIPOSE TISSUE (BAT) is a thermogenic tissue specialized in the production of heat in demanding situations such as cold exposure, during arousal from hibernation, or by the cold experienced after birth. This process is called facultative thermogenesis. The production of heat is accomplished by a mitochondrial protein, called uncoupling protein-1 (UCP1), the specific marker of BAT. Adrenergic stimulation is the main effector for the activation of UCP1, and thyroid hormones, specifically triiodothyronine (T 3 ), have been described as being necessary for the full expression of UCP1 in rats (3, 4) . Moreover, T 3 in BAT is locally produced from thyroxine (T 4 ) via a deiodinase that plays an important role generating the T 3 required for UCP1 expression (5) .
The deiodinases are enzymes that regulate thyroid hormone availability in peripheral tissues. Three different deiodinases have been described that catalyze outer-and inner-ring deiodination. Outer-ring deiodination is a key pathway of thyroid hormone metabolism that leads to the production of T 3 , whereas innerring deiodination results in the formation of inactive compounds. Most of the T 3 present in tissues is produced from T 4 via outer ring 5Ј-deiodination. Two isoenzymes catalyze this activating pathway: type I and type II 5Ј-iodothyronine deiodinases (D1 and D2). D1 and D2 differ in their kinetic characteristics, sensitivity to inhibition by 6-N-propyl-2-thiouracil (PTU), tissular distribution, and response to thyroid status (23) . Different from D1, D2 is insensitive to PTU, it prefers T 4 as substrate, and its Michaelis-Menten constant is in the nanomolar range. D2 activity is upregulated in hypothyroidism and inhibited by T 4 (26, 47, 48) . D2 activity is localized in brain, adenohypophysis, BAT, pineal gland, and the maternal side of the placenta, among other tissues (24, 26, 39, 44, 53) . D2 activity is regulated in rat tissues, glial cells, or brown adipocytes by a number of factors such as thyroid hormones (26, 27, 47) , adrenergic agents (19, 22, 32, 35, 38, 39, 44) , cAMP (10, 17, 22) , growth factors (11) , and insulin (29, 46) .
The cDNAs coding for the three deiodinases have been isolated in rat, human, and other species (2, 12, 13) . Sequence analysis has demonstrated that all of them contain an in-frame TGA codon that is translated as selenocysteine due to the presence of a specific structure, named selenocysteine insertion sequence (SECIS), in the 3Ј untranslated region of their mRNAs (2, 6) . Analysis of D2 expression in human tissues has shown that D2 is also present in human heart, skeletal muscle, and thyroid (12, 42) .
In rat BAT, D2 activity is stimulated by hypothyroidism (27) and by cold exposure, norepinephrine (NE), and adrenergic stimuli (44) . T 3 -induced hyperthyroidism augmented the response to NE (47) . These situations also increase D2 mRNA levels (12) . As already mentioned, D2 activity produces most of the T 3 found in BAT (45) , which saturates nuclear T 3 receptors, and the T 3 produced is necessary for a complete thermo-genic function, namely the full expression of the uncoupling protein UCP1, specific marker of BAT (5) . Besides, BAT D2 activity is upregulated by insulin (46) , as shown after insulin injection, or in diabetic rats, as well as in floating rat brown adipocytes (29) . In these cells, D2 activity is stimulated by adrenergic agents, and a synergy between ␣ 1 -and ␤-adrenergic pathways has been described (32, 38) , whereas in cultures of mouse brown adipocytes the main pathway is ␤-adrenergic (35) .
Using primary cultures of rat brown adipocytes, we have previously shown that D2 activity is poorly stimulated by NE or cAMP analogs and that T 3 is required for and amplifies the adrenergic response 10-to 20-fold (19) . The effect of T 3 is exerted when NE or ␤ 3 -adrenergic agents are used and is only poorly mimicked when cAMP-elevating agents are used. The stimulatory effect of T 3 on the adrenergic responses of D2 activity overcomes the inhibition caused by T 4 , and such increases are proportional to the time of preexposure to T 3 (19) . The T 3 ϩ NE effect requires de novo protein synthesis and is fully inhibited by actinomycin.
In the present study, we have studied the regulation of D2 mRNA expression by adrenergic stimulation and by T 3 by use of primary cultures of rat brown adipocytes differentiated in culture from preadipocytes. Our results disclose a novel role of T 3 in the regulation of D2 mRNA levels, both in cooperation with NE and by itself, indicating the importance of T 3 for the brown adipocyte.
MATERIALS AND METHODS

Materials.
The source of most of the reagents used has been previously described (21) . Newborn calf serum (NCS) was purchased from Flow (Paisley, Scotland) or from GIBCO Life Technologies (Uxbridge, UK). Isoproterenol (ISO) and 8-bromoadenosine 3Ј,5Ј-cyclic monophosphate (8-BrcAMP) were obtained from Sigma Chemical (St. Louis, MO). BRL-37344 was kindly provided by SmithKline Beecham Pharmaceuticals (Welwyn, UK). Ion exchange resins AG1-X8 and AG50W-X2 were obtained from Bio-Rad (Richmond, CA). Oligo(dT) cellulose was obtained from New England Biolabs (Beverly, MA), TRIzol from GIBCO-BRL Life Technologies, AmpliTaq Gold DNA polymerase from Roche Molecular Systems (Branchburg, NJ), and AMV reverse transcriptase (RT) from Promega (Madison, WI).
Cultures of brown adipocytes. Precursor cells were obtained from the interscapular BAT of 20-day-old rats (Sprague-Dawley), isolated according to the method described by Néchad et al. (30) by using collagenase digestion (0.2%) in DMEM ϩ 1.5% BSA at 37°C and filtered through 250-m silk filters. Mature cells were allowed to float, and the infranatant was filtered through 25-m silk filters and centrifuged. Precursor cells were seeded in 25-cm 2 culture flasks or 145-cm 2 plates at a density of 1,500-2,000 cells/cm 2 on day 1 and grown in DMEM supplemented with 10% NCS, 3 nM insulin, 10 mM HEPES, 50 IU of penicillin, and 50 g of streptomycin/ml and 15 M ascorbic acid. Culture medium was changed on day 1 and every 2-3 days until the experiment was performed. Precursor cells proliferate actively under these conditions, reach confluence on the 4th or 5th day after seeding (40,000-60,000 cells/cm 2 ), and then differentiate into mature brown adipocytes. Most studies and treatments were done in fully differentiated brown adipocytes (on the 9th day after seeding). For deiodinase activity, 25-cm 2 flasks were used, and for mRNA studies, 2-3 plates (145 cm 2 ), seeded at the same cellular density, were pooled. Both NCS and hypothyroid (Hypo) serum were used for culture. The latter was obtained by depleting NCS of thyroid hormones with the anion exchange resin AG1-X8, as described (43) . Hypo serum contained ϳ10% or less of the original amount of thyroid hormones, as assessed by RIA (36) . In NCS, concentrations of T 4 and T3 were 77 and 1.3 nM, respectively, before its dilution with medium. These levels decreased to 2.2 nM T 4 and 0.13 nM T3 in Hypo serum. In some experiments, T 3 and T4 concentrations were measured in medium and cells (after purification of the extracts) by means of specific RIAs (36) .
Free T 3 concentrations were measured by ultrafiltration as described (36) . Free T 3 concentration was 2 or 4% of the total T 3 when 10 or 5% serum, respectively, (either NCS or Hypo serum) was used. The actual free T 3 concentrations were 5-10 pM when 10% NCS was used and 200-500 pM T 3 when 10 nM T 3 was added to the culture medium supplemented with 10 or 5% Hypo serum, respectively.
RNA preparation and Northern blot analysis. For the isolation of poly(A)
ϩ RNA, cells were collected and mRNA isolated using oligo(dT) cellulose as described (52) . For Northern analysis, poly(A) ϩ (5-7 g) was denatured and electrophoresed on a 2.2 M formaldehyde/1% agarose gel in 1ϫ MOPS buffer (pH 7.0) and transferred to nylon membranes (Nytran) as described (18, 21) . A 1.988-kb fragment of the rat D2 cDNA clone (12) , corresponding to the entire coding region of the rat D2, 580 nucleotides from the 5Ј region and 30 nucleotides of the 3Ј end, was used as a probe by labeling with [␣-
32 P]dCTP with the use of random primers (Ͼ10 8 cpm/g DNA). Filters were hybridized for 20 h at 50°C [40% formamide, 20 g/ml salmon sperm DNA, 50 g poly(A), and 50 g poly(C)/ml, 5ϫ saline sodium citrate (SSC), 2ϫ Denhardt's, 0.1% SDS] and washed four times in 2ϫ SSC/0.2% SDS at room temperature for 15 min and then twice in 0.1ϫ SSC/0.2% SDS at 65°C for 20 min. Autoradiograms were obtained from the filters and quantified by laser computer-assisted densitometry (Molecular Dynamics, Sunnyvale, CA). The filters were hybridized with cyclophilin as a control to correct for differences between lanes in the amount of poly(A) ϩ mRNA (14) . All of the experiments were repeated 2-3 times, using Northern blot analysis in all. The more complete or representative experiments are shown in the figures.
RT-PCR assay. One microgram of total RNA (TRIzol, GIBCO) was used for RT-PCR amplification under the conditions previously described (12) . We used the same RNA samples without RT reaction as controls. The PCR reaction conditions were 94°C for 5 min, and 35 cycles at 94°C for 1 min, 55°C for 1 min, and 72°C for 1 min, and a final 7-min period at 72°C, using AmpliTaq Gold DNA polymerase. The specific oligonucleotides used for amplification of a 590-bp product were: sense, 5Ј-ACT CGG TCA TTC TGC TCA AG-3Ј and antisense, 5Ј-TTC AAA GGC TAC CCC ATA AG-3Ј, as previously described (12) . After gel electrophoresis in 1% agarose, the PCR products were transferred to a filter and hybridized with a radiolabeled, nested oligonucleotide rat D2 probe (AAT GCC ACC TTC TTG ACT TT), using [␥-
32 P]ATP, as previously described (12) . The optimal conditions were chosen to avoid the presence of DNA in the samples, unspecific annealing in the PCR reaction, etc.
Determination of D2 activity. Cells were scraped, collected in buffer A [0.32 M sucrose, 10 mM HEPES, 10 mM dithiothreitol (DTT), pH 7.0] and homogenized. D2 activities were determined in homogenates by measuring the release of iodide as described (27) , with modifications (19, 33) , using as final concentrations 2 nM T 4 (50.000 cpm [
125 I]T4), 1 M T3, 50 mM DTT, 1 mM PTU, 80-100 g protein/100 l of total volume, pH 7.0, during 1 h at 37°C. In these conditions, Ͼ95% of the activity was insensitive to inhibition with PTU. Each cell homogenate was tested in triplicate using 2-3 culture flasks per treatment. Protein content was determined by the method of Lowry (28) after precipitation of the homogenates with trichloroacetic acid to avoid interference of DTT in the colorimetric reaction (19) . Results were expressed in femtomoles per hour per milligram of protein.
The high specific activity [ 125 I]T4 used was obtained in our laboratory (Ͼ3,000 Ci/g) with the use of chloramine T and T 3 as substrate (19, 33) . Before each assay, [
125 I]T4 was purified by paper electrophoresis to separate the contaminating iodide, using ammonium acetate 0.05 M, pH 6.8. The amount of iodide in the blanks assay was routinely less than 1% of the total radioactivity. Preliminary experiments were performed to validate the assay: 1) the production of equimolar amounts of iodide and T 3, 2) the linear production of iodide by use of increasing amounts of protein, and 3) the within-assay coefficient of variation that was Ͻ5%.
Statistical analysis. Mean values Ϯ SE are given. One-way analysis of variance (ANOVA) was done, after homogeneity of variance was ensured, using square roots or logarithmic transformations if the homogeneity was not found with the raw data. Significance of differences between groups was assessed using the protected least significant difference test. All calculations were done as described (49) .
RESULTS
We have previously shown that, in primary cultures of rat brown adipocytes, the adrenergic stimulation of D2 activity requires the presence of T 3 (19) . This T 3 requirement is similar to the one observed for the adrenergic stimulation of UCP1 mRNA in the same cell model (20) .
D2 mRNA induction by NE and T 3 . In rat BAT, D2 mRNA presents several bands at 7.5, 4.0, 2.5, and 2.0 kb, the first being the most abundant. D2 mRNA expression is clearly stimulated in the BAT of cold-exposed rats (12) . In the present study, we used Northern blot analysis of poly(A) ϩ -enriched mRNA from differentiated brown adipocytes. D2 mRNA expression was undetectable using regular culture conditions no matter the amount or type of serum used (not shown) or when the cells were treated with NE alone (Fig. 1A,  lanes 1 and 4) . The combined addition of NE and T 3 led to increases in D2 mRNA expression (lane 3), in parallel with the findings for the adrenergic stimulation of D2 activity (19) , where T 3 was a requirement for NE to become effective whereas NE or T 3 separately had no effect. Moreover, in the absence of adrenergic stimulation, prolonged exposure (40 h) to T 3 increased D2 mRNA levels (2-fold) (Fig. 1A, lane 2) , whereas short exposures to T 3 did not increase D2 mRNA (not shown).
We also compared the effect of 24-and 72-h exposure to T 3 on D2 mRNA in cells treated with or without NE (Fig. 1B) . In the absence of NE, no effect was observed after 24-h exposure to T 3 (lane 1), whereas prolonged exposure (72 h) to T 3 increased D2 mRNA above basal levels (lane 2). In the presence of NE, D2 mRNA increased sixfold after a short exposure to T 3 and a further fivefold (a total of 30-fold) after a long (72 h) exposure to T 3 ( lanes 3 and 4) . ϩ RNA were loaded per lane. D2 mRNA, cyclophilin (Cy) mRNA, and the D2-to-Cy ratio (D2/Cy) are shown (means Ϯ SE from 3 experiments). B: effect of short and long exposure time to T3 on the adrenergic induction of D2 mRNA. Nineday-old cultures of brown adipocytes were maintained during the last 72 h in medium supplemented with 5% hypothyroid serum. Cells were cultured in the presence of 10 nM T3 during the last 24 or 72 h and in the presence or absence of 5 M NE during the last 6 h. Five micrograms of poly(A) ϩ RNA were loaded per lane. Hybridization with a cyclophilin cDNA was used to correct for differences between lanes and D2/Cy is shown. Graph shows means Ϯ SE of 5 different experiments. *P Ͻ 0.05, vs. treated with only T3 for 72 h. C: RT-PCR assay. One microgram of total RNA from 9-day-old cultures of brown adipocytes was used for RT-PCR amplification. Cells were treated with 5% hypothyroid serum, with 10 nM T3 for 24 or 72 h in the absence or presence of 5 M NE during the last 6 h, or with NE alone. For each sample, reactions were performed with (ϩRT) and without (ϪRT) reverse transcriptase. As negative controls, mixtures with no RNA (C) or with muscle RNA were run. PCR products were separated on an agarose gel, transferred to a nylon membrane, and probed with a radiolabeled rat D2 oligonucleotide. PCR products are shown after ethidium bromide staining as well as the hybridization with the D2 oligonucletide probe.
To see whether the NE response was too low to be measured using poly(A) ϩ mRNA, we used RT-PCR amplification, with 24-or 72-h exposure to T 3 , in the presence or absence of NE (Fig. 1C) . After RT-PCR amplification, we observed essentially the same facts as with poly(A) ϩ mRNA: NE alone was unable to increase D2 mRNA (undetectable levels comparable to basal levels or muscle), whereas NE ϩ T 3 induced large increases (24 or 72 h); T 3 alone resulted in an intermediate response (lower, but detectable, at 24 h). Although this technique amplifies exponentially any small amount of DNA and does not allow a quantitative approach, it confirms that T 3 induces D2 mRNA expression by itself besides amplifying the adrenergic stimulation. With the use of NE alone, D2 induction is undetectable.
Induction of D2 activity by NE and T 3 . In parallel, we examined the adrenergic stimulation of D2 activity using different exposure times to T 3 (Fig. 2) . The presence of T 3 per se (or NE alone, Fig. 2 , dashed line) did not increase D2 activity. Adrenergic increases of D2 activity were larger in cells exposed to T 3 from confluence (72 h) than in those exposed for a shorter time (24 h) to T 3 . The effect of T 3 was also examined in the absence of insulin, which increases D2 activity in BAT, and the results were similar, although lower, indicating that the T 3 effect is independent of insulin. The increases observed in D2 activity after prolonged exposure to T 3 were modest compared with those observed at the mRNA level.
Effect of high doses of T 3 . We then examined whether high doses of T 3 (100 nM) inhibit D2 mRNA in brown adipocytes, as described in pituitary cells (25) . Figure  3A shows that D2 mRNA expression is not suppressed by a 100 nM dose of T 3 in either the presence or absence of NE. We further tested in the presence of NE a larger T 3 dose (500 nM), which did not inhibit D2 expression but induced further increases in D2 mRNA (2.5-fold vs. 10 nM T 3 ϩ NE). T 3 concentrations were very high, as measured by specific RIAs (50-and 250-fold increases in the medium and cells, when 100 and 500 nM T 3 , respectively, were used vs. 10 nM T 3 ). In parallel, we tested whether these T 3 doses inhibited D2 activity (Fig. 3B) . Increasing amounts of T 3 inhibited the adrenergic stimulation of D2 activity, effects that were detectable from 20 nM T 3 , and maximal inhibition was observed when using 100 nM T 3 .
Effect of adrenergic agonists. We have previously shown (19) that, in cultured brown adipocytes, the adrenergic responses of D2 activities were mediated mainly by NE, whereas cAMP analogs did not reproduce the NE effect. The thermogenic responses in BAT have been shown to be mediated via ␤ 3 -adrenergic receptors (55) . We tested the effect of the ␤ 3 -adrenergic agonist BRL-37344, compared with NE and ISO, on D2 activity and D2 mRNA expression (Fig. 4, A and B) . Using dose-response curves, we observed that BRL-37344 is more potent than NE and ISO at the dose of 0.1 M (P Ͻ 0.05) in the stimulation of D2 activities (half-maximal concentrations were 0.05 M for BRL- 3 . A: effect of high doses of T3 on the adrenergic induction of D2 mRNA. Brown adipocytes were cultured as described. Cells were cultured in the presence of 10 or 100 (or 500) nM T3 during the last 72 h and in the presence or absence of 5 M NE during the last 6 h.
Five micrograms of poly(A)
ϩ RNA were loaded per lane. Hybridization with a cyclophilin cDNA was used to correct for differences between lanes and D2/Cy is shown. Graph shows the mean Ϯ SE of 2 different experiments, with 10 nM T3 ϩ NE taken as 100%. B: effect of high doses of T3 on the adrenergic induction of D2 activity. Eight-day-old cultures of brown adipocytes were cultured in medium supplemented with 10% hypothyroid serum in the presence of increasing amounts of T3 (10, 20, 50, 100, 200, 500, and 1,000 nM) during the last 24 h and NE (5 M) during the last 6 h. The values from 10 nM T3 ϩ NE were taken as 100%. Line shows the values for NE or T3 alone. Data are means Ϯ SE (n ϭ 4, done in triplicate) of 2 flasks from 2 different experiments. * P Ͻ 0.05, vs. cells treated with 10 nM T3 for 24 h (100%).
vs. 0.2 M for NE and ISO). A plateau was reached at higher concentrations.
With respect to D2 mRNA expression, similar levels were detected with the use of equimolar concentrations of NE or the ␤ 3 -adrenergic agonist BRL-37344 in the presence of T 3 (Fig. 4B) , although the latter seemed slightly more potent (not significant). Additionally, we tested the effect of 8-BrcAMP and found poor effects compared with NE (P Ͻ 0.05 vs. NE; Fig. 4B ). This is in agreement with the low effect of cAMP analogs that we reported for D2 activity (19) .
D2 mRNA inductions are blocked by actinomycin D and increased by cycloheximide. We studied whether D2 mRNA adrenergic inductions were dependent on increases in gene transcription and required de novo protein synthesis. Cells were exposed for 1 or 3 days to T 3 and to NE for 7 h, in the presence or absence of either actinomycin D (Act) or cycloheximide (CHX) (both added 15 min before NE). We had previously tested the complete inhibition of protein synthesis using these doses of CHX in culture (20) . Addition of Act or CHX for periods longer than 20 h was toxic for the cells. Figure 5A shows that Act inhibits the induction of D2 mRNA, suggesting that the adrenergic response requires increases in gene transcription, whereas CHX increases D2 mRNA levels, indicating that inhibition of de novo protein synthesis for 7 h results in accumulation of the D2 mRNA, especially of a short mRNA species (ϳ1.9 kb). Similar results were obtained when T 3 was added for a short or a long time (ϩNE) (Fig. 5A) . When both inhibitors were added to T 3 alone (in the absence of NE), the results were similar to those using NE ϩ T 3 (see Fig. 5B ). Addition of CHX to cells in basal conditions or using NE alone did not result in accumulation of mRNA (data not shown), indicating that such an accumulation is found only in the presence of T 3 .
D2 mRNA stability. We explored whether the effect of T 3 could be due to stabilization of D2 mRNA transcripts leading to increases in its half-life, as this effect of T 3 is observed in other T 3 -dependent genes in brown adipocytes, such as UCP1, malic enzyme, or S14 (3, 18, 20, 37) .
To measure the stability of the D2 mRNA, brown adipocytes were cultured in the presence of T 3 for 1 or 3 days and exposed to NE (5 M) during the last 10 h to stimulate D2 mRNA expression. Thereafter, Act was added to some of the flasks, and cells were harvested at different times for mRNA preparation. Because D2 mRNA expression was decreasing during this time, the appropriate controls were run in parallel. Figure 6 shows first that, in the absence of Act, a decrease in D2 mRNA expression occurred during the period studied, as the effect of NE decreased between 10 and 18 h, so D2 mRNA expression decreased by 50% after 7 h, both when T 3 was added for long or short times (1 or 3 days). Act induced a further reduction in D2 mRNA, but no significant changes were observed between exposure to T 3 for 1 or 3 days. D2 mRNA half-life was ϳ6 h, so the A: by use of NE and T3 for 1 or 3 days, 9-day-old cultures of brown adipocytes were maintained during the last 72 h in medium supplemented with 5% hypothyroid serum. Cells were cultured in the presence of 10 nM T3 during the last 24 or 72 h, and 5 M NE was added during the last 7 h. Act (5 g/ml) or CHX (25 M) was added 15 min before NE. Five micrograms of poly(A) ϩ RNA were loaded per lane. Hybridization with a cyclophilin cDNA was used to correct for differences between lanes and D2/Cy is shown (mean Ϯ SE from 3 experiments). B: with T3 alone, the same protocol was used as in A, except that T3 was added for 72 h (without NE), and Act (5 g/ml) or CHX (15 M) was added during the last 14 h (mean Ϯ SE from 2 experiments). Fig. 4 . A: dose-response curves for the adrenergic stimulation of D2 activity using NE, isoproterenol (ISO), and BRL-37344 (BRL). Eightday-old cultures of brown adipocytes were maintained during the last 24 h in medium supplemented with 10% hypothyroid serum and 10 nM T3. Cells were exposed to different concentrations of NE, ISO, and BRL during the last 6 h. Data are means Ϯ SE (n ϭ 4, triplicates) of 2 flasks from 2 different experiments. * P Ͻ 0.05, BRL vs. NE. B: adrenergic stimulation of D2 mRNA using NE, BRL, and 8-bromoadenosine 3Ј,5Ј-cyclic monophosphate (8-BrcAMP). Nineday-old cultures of brown adipocytes were maintained during the last 72 h in medium supplemented with 5% hypothyroid serum. T3 (10 nM) was added during the last 24 h, and 0.2 M NE or BRL or 0.5 mM 8-BrcAMP was added during the last 6 h. Five micrograms of poly(A)
ϩ RNA were loaded per lane. D2 mRNA, cyclophilin mRNA, and D2/Cy are shown (mean Ϯ SE of two experiments). presence of T 3 for short or long times does not seem to play a role in increasing D2 mRNA stability. Nevertheless, as we cannot measure D2 mRNA half-life in the absence of T 3 , it is likely that T 3 is playing a role in the stabilization of D2 mRNA transcripts.
DISCUSSION
The main regulator of D2 activity in BAT is cold exposure, via the adrenergic stimulation (44), a situation in which D2 provides the T 3 required for the full expression of UCP1, the specific marker of BAT (5). T 3 plays other important roles in brown adipocytes, increasing mitocondriogenesis, the expression of lipogenic markers (18, 37) , and favoring differentiation programs. The action of T 3 on D2 expression does not seem to be an indirect effect linked to the differentiation program, but rather an action required for the NE action.
NE. D2 is stimulated adrenergically in floating adipocytes (32) , and a synergy between the ␤-and ␣ 1 -adrenergic pathways was found (38) , the adrenergic stimulation of D2 being mostly ␤-adrenergic in mouse brown adipocytes (35) . We have shown that T 3 is an absolute requirement for the adrenergic stimulation of D2 and amplifies this response (19) .
In the present study, we analyzed the mechanisms involved in the stimulation of D2 mRNA expression by use of rat brown adipocytes in culture. A predominant band of 7.5 kb and several other weaker bands were observed for D2 mRNA, as described (12) . Using poly(A) ϩ , we did not detect D2 mRNA in basal conditions or when adding NE alone. Using an RT-PCR technique, we were also unable to detect increases in D2 mRNA in response to NE alone, and the presence of T 3 was required. This lack of response could be due to the hypothyroidism-induced impairment of the ␤-adrenergic response that results in a lower density of ␤ 1 -adrenergic receptors (AR), and lower cAMP levels (both decreased by 60%) (40) . This effect of hypothyroidism has been reported for many tissues (51) and recently has been addressed extensively in BAT for ␤ 1 -, ␤ 2 -, and ␤ 3 -AR (40, 41) . Treatment with T 3 slowly restores first the density of ␤ 1 -AR and later the capacity to produce cAMP, suggesting that the lower cAMP production reflects a fault at the postreceptor level (40) . Nevertheless genes such as UCP1, which are stimulated adrenergically and whose expression is low in hypothyroid rats, restore their levels a few hours after T 3 injection (4), much before cAMP production is normalized. The lack of response to NE and the T 3 requirement for NE action goes much further than the simple restoration of the ␤ 1 -AR density. Moreover, the changes in ␤ 3 -AR density in response to hypothyroidism and T 3 are opposite to the ones observed for ␤ 1 -AR density (41) .
Indeed, a cAMP response element (CRE) has been identified in the 5Ј UT region of the human D2 promoter (Ϫ92/Ϫ85) (1), and D2 mRNA responds quickly to forskolin and 8-BrcAMP in astrocytes (34) , indicating that CRE seems to be an important regulatory element in the D2 promoter. To our knowledge, no functional CRE has been identified yet in the rat D2 promoter.
T 3 and NE. The adrenergic stimulation of D2 mRNA in cultured brown adipocytes requires the presence of T 3 . This finding is similar to what is found for the adrenergic stimulation of UCP1 mRNA, where a synergy between NE and T 3 is required, postulated to be exerted via CREs. In the UCP1 gene, an enhancer region has been found that has several thyroid response elements, retinoic acid response elements, and possibly peroxisome proliferator-activated response elements that synergized with the response of NE via cAMP. The cooperative interaction between the T 3 and NE actions is firmly stablished (3, 4) , but the specific proteins involved (coactivators) have not yet been identified. The recruitment of coactivators would increase the affinity or phosphorylation of CCAAT/enhancerbinding protein/p300 to increase transcription. Another possible candidate is PGC-1, the coactivator 1 for peroxisome proliferator-activated receptor-␥ (PPAR␥), induced in BAT upon cold exposure. The participation of these proteins in the synergistic action of NE and T 3 is not elucidated. Recent reports using mice with targeted disruption of the D2 gene suggest that the T 3 derived from D2 is essential for the thyroidsympathetic synergy required for adaptative thermogenesis (15) .
The adrenergic responses behave as ␤ 3 -adrenergic at the mRNA level, in agreement with previous reports using CGP-12177A (19, 35) , and the responses are similar for D2 activity and mRNA. The effect of NE on D2 activity and mRNA is only poorly reproduced when using . This suggests either that cAMP by itself is not the only pathway of activation or that T 3 interferes in its transduction pathway. Other signaling pathways, such as p38 mitogen-activated protein kinase, have been recently reported to be activated in response to ␤ 3 -agonists in brown adipocytes, indicating the need for this signaling pathway, in addition to elevation of cAMP levels (8) . We have measured cAMP levels in our cells (unpublished results), which increase with the use of NE, BRL-37344, or other ␤ 3 -agonists to levels comparable to those obtained using 8-BrcAMP (150-200 up to 500 pmol cAMP/mg protein), levels that increase twofold in the presence of T 3 . The possibility that the CRE is inhibited by the action of serum, via c-jun, as has been described in the UCP1 promoter (54) , is unlikely, because we find no response to NE either in the absence of serum.
T 3 . In addition, we have demonstrated that T 3 by itself increases D2 mRNA expression. Although the extent of this increase may seem modest, it is an unexpected finding. The increased D2 mRNA expression observed with the use of T 3 could be due to direct stimulation of transcription (as Act blunts it), stimulation of factors required for transcription, or stabilization of the preexisting mRNA, as the T 3 effect requires long times to be observed. T 3 could also stimulate basal D2 expression by increasing the basal adenylyl cyclase activity, as T 3 reduces G i levels (9) . Nevertheless, basal cAMP levels are not modified by addition of T 3 in our cells. Of note, RT-PCR is able to amplify D2 transcripts after 24 h of T 3 treatment alone, a fact not observed when NE is used alone.
This effect of T 3 is in contrast to what is found in vivo in other tissues such as brain (7, 12, 26) or pituitary cells (25) , where T 3 inhibits D2 mRNA by 50%, suggesting specific modulation of D2 in each cell. The inhibition of D2 activity by T 3 is much lower than that of T 4 and reverse T 3 (47, 48) . In BAT, T 3 has little ability, if any, in inhibiting D2 activity and even 2-fold increases were reported (47) . We found that constant infusion of T 3 into rats stimulated D2 activity in BAT and brain from fetal and adult rats (16, 31) . In the present study, we observe clear inhibition of D2 activity when using 20 nM T 3 or higher, but at the mRNA level, we do not observe decreases in D2 expression, even when very high T 3 doses are used, and further increases in D2 mRNA are observed with the use of 500 nM T 3 (a T 3 dose that increase T 3 concentrations Ն250-fold in cells and medium).
Mechanisms. The experiments done using CHX and Act indicate that D2 mRNA induction using NE ϩ T 3 or T 3 is activated at the transcriptional level and that the inhibition of de novo protein synthesis results in accumulation of mRNA, especially of a shorter mRNA species. CHX treatment of T 3 -exposed cells produces a marked increase in a 1.9-kb mRNA species that was barely detectable in control cells (Fig. 5) . This transcript might be a short-lived product generated by alternative mRNA processing. The nature of this mRNA is unknown, but it might correspond to a 1.9-kb D2 cDNA isolated from brown fat (12) that does not code for an active protein because it is lacking a putative SECIS element. If this is the case, expression of this shorter mRNA might be an important regulatory mechanism of expression of active D2 enzyme. The accumulation of D2 mRNA with the use of CHX has been reported in pituitary cells (25) (mRNAs sizes were not described) and in pineal glands, where a short band is also observed (22) . Of note, CHX per se, or in the presence of NE without T 3 , is unable to accumulate shorter or larger mRNA species (results not shown).
The studies performed to determine whether a prolonged exposure to T 3 contributes to increases in D2 mRNA half-life suggest that this is not the case. Nevertheless, we do not exclude the possibility that T 3 is inducing a stabilization of the D2 mRNA transcripts, as we were unable to measure D2 mRNA half-life in the absence of T 3 . A much shorter D2 mRNA half-life (2 h instead of the 6 h we find) has been reported in pituitary cells (25) , suggesting that the presence of T 3 might increase D2 mRNA half-life.
In summary, we have demonstrated that T 3 is an absolute requirement for the adrenergic stimulation of D2 mRNA (and activity) in brown adipocytes. This stimulation occurs mainly via ␤ 3 -adrenergic receptors. T 3 by itself is able to increase D2 mRNA after prolonged exposure, and its presence is required for the accumulation of D2 mRNA species after treatment with CHX. Additional work is necessary to elucidate the mechanisms by which this novel role of T 3 takes place. The findings reported here are important, as D2 mRNA expression has not been studied in brown adipocytes, and give a new dimension to the important role of T 3 in the regulation and maintenance of its own production in BAT besides its importance in the stimulation of the thermogenic function, namely the expression of UCP1, the specific marker of brown adipocytes.
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